MRI as a method to reveal in-vivo pathology in MS

  • D. W. Paty
Conference paper


Multiple sclerosis is primarily a disease of myelin. The degeneration of neurons and axons in MS has not been considered to be a major factor until recently. Magnetic resonance (MR) techniques have helped a great deal in describing the evolution of MS lesions over time. Some pathological and MR studies have shown that in the chronic stage of MS, axonal loss occurs. Further studies using MR techniques should help to understand this phenomenon as it occurs in vivo.


Multiple Sclerosis Multiple Sclerosis Lesion Axonal Loss Magnetic Resonance Technique IFNB Multiple Sclerosis Study Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arnold DL, Matthews PM, Francis G, Antel J, et al (1991) Proton MR spectroscopic imaging (SI) for metabolic characterization of the brain plaques of demyelinating disease. Neurology 41: 144Google Scholar
  2. Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, Antel JP (1994) Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 36: 76–82PubMedCrossRefGoogle Scholar
  3. Barnes D, McDonald WI, Tofts PS, Johnson G, Landon DN (1986) Magnetic resonance imaging of experimental cerebral oedema. J Neurol Neurosurg Psychiatry 49: 1341–1347PubMedCrossRefGoogle Scholar
  4. Barnes D, McDonald WI, Landon DN, Johnson G (1988) The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain 111: 83–94PubMedCrossRefGoogle Scholar
  5. Barnes D, Munro PMG, Youl BD, Prineas JW, McDonald WI (1991) The longstanding MS lesion. Brain 114: 1271–1280PubMedCrossRefGoogle Scholar
  6. Birken DL, Oldendorf WH (1989) N-acetyl-L-aspartic acid: a literature review of a compound prominent in H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 13: 23–31PubMedCrossRefGoogle Scholar
  7. Fog T, Linnemann F (1970) The course of multiple sclerosis in 73 cases with computer-designed curves. Acta Neurol Scand [Suppl] 46: 1–175Google Scholar
  8. Grossman RI, Lenkinski RE, Ramer KN, Gonzalez-Scarano F, Cohen JA (1992) MR proton spectroscopy in multiple sclerosis. AJNR 13: 1535–1543PubMedGoogle Scholar
  9. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF (1993) Correlation between magnetic resonance imaging and lesion development in chronic, active multiple sclerosis. Ann Neurol 34: 661–669PubMedCrossRefGoogle Scholar
  10. Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DPE, Moseley IF, Rudge P, McDonald WI (1990) Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 113: 1477–1489PubMedCrossRefGoogle Scholar
  11. Koopmans RA, Li DKB, Oger JJ, Kastrukoff LF, Jardine C, Costley L, Hall S, Grochowski EW, Paty D W (1989a) Chronic progressive multiple sclerosis: serial magnetic resonance brain imaging over six months. Ann Neurol 26: 248–256PubMedCrossRefGoogle Scholar
  12. Koopmans RA, Li DKB, Oger JJF, Mayo J, Paty DW (1989b) The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 39: 959–963PubMedGoogle Scholar
  13. Koopmans RA, Li DK, Zhu G, Allen PS, Penn A, Paty DW (1993) Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products [letter]. Lancet 341: 631–632PubMedCrossRefGoogle Scholar
  14. Ludwin SK (1988) Remyelination in the central nervous system and peripheral nervous system. Adv Neurol, Funct’l Rec In Neurol Dis 47: 215–254Google Scholar
  15. Lumsden CE (1951) Fundamental problems in the pathology of multiple sclerosis and allied demyelinating diseases. BMJ 1: 1035–1043PubMedCrossRefGoogle Scholar
  16. MacKay AL, Whittall KP, Cover KS, Li DK, Paty DW, et al (1991) In vivo T2 relaxation measurements of brain may provide myelin concentration. Society of Magnetic Resonance in Medicine, 10th Annual Meeting, Aug 1991. Book of Abstracts 1: 917Google Scholar
  17. Matthews PM, Francis G, Antel J, Arnold DL (1991) Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41: 1251–1256PubMedGoogle Scholar
  18. McDonald WI, Miller DH, Barnes D (1992) The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 18: 319–334PubMedCrossRefGoogle Scholar
  19. Miller DH, Rudge P, Johnson G, Kendall BE, Macmanus DG, Moseley IF, Barnes D, McDonald WI (1988) Brain 111: 927–939PubMedCrossRefGoogle Scholar
  20. Miller DH, Barkhof F, Nauta JJ (1993) Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 116: 1077–1094PubMedCrossRefGoogle Scholar
  21. Minderhoud JM, Mooyaart EL, Kamman RL, et al (1992) In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. Arch Neurol 49: 161–165PubMedGoogle Scholar
  22. Moore GRW (1995) Pathology. In: Paty DW, Ebers G (eds) Multiple sclerosis.Google Scholar
  23. FA Davis, Philadelphia Moore GRW, Neumann PE, Suzuki K, Lijtmaer HN, Traugott U, Raine CS (1985) Balo’s concentric sclerosis: new observations on lesion development. Ann Neurol 17: 604–611CrossRefGoogle Scholar
  24. Narayana PA, Wolinsky JS, Jackson EF, McCarthy M (1991) Magnetic resonance of multiple sclerosis: correlation between proton spectroscopy and Gd-DTPA enhancement. Society of Magnetic Resonance in Medicine, 10th Annual Meeting, Aug 1991. Book of Abstracts 1: 82Google Scholar
  25. Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M (1991) Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 180: 467–474PubMedGoogle Scholar
  26. Newcombe J, Hawkins CP, Henderson CL, Patel HA, Woodroofe MN, Hayes GM, Cuzner ML, MacManus D, du Boulay EP, McDonald WI (1991) Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain 114: 1013–1023PubMedCrossRefGoogle Scholar
  27. Paty DW (1987) Multiple sclerosis: assessment of disease progression and effects of treatment. Can J Neurol Sci 14: 518–520PubMedGoogle Scholar
  28. Paty DW, Li DKB (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 43: 662–667PubMedGoogle Scholar
  29. Prineas JW, Barnard RO, Ruesz T, Kwon EE, Sharer L, Cho ES (1993) Multiple sclerosis. Pathology of recurrent lesions. Brain 116: 681–693PubMedCrossRefGoogle Scholar
  30. Ross BD (1991) Biochemical considerations in H spectroscopy. Glutamate and glutamine; myoinositol and related metabolites. NMR in Biomedicine 4: 59–63PubMedCrossRefGoogle Scholar
  31. Stewart WA (1989) Proton spin relaxation as a means of characterizing the pathology of multiple sclerosis. Thesis, The University of British Columbia, Vancouver, CanadaGoogle Scholar
  32. Stewart WA, Hall LD, Berry K, Paty DW (1984) Correlation between NMR scan and brain slice: data in multiple sclerosis. Lancet ii: 412CrossRefGoogle Scholar
  33. Tourtellotte WW (1992) Issues in multiple sclerosis. A focused disease oriented research program. Ital J Neurol Sci 13: 47–53PubMedCrossRefGoogle Scholar
  34. Waxman SG (1988) Advances in neurology. Functional recovery in neurological disease. Adv Neurol 47: 157–184PubMedGoogle Scholar
  35. Willoughby EW, Grochowski E, Li DKB, Oger J, Kastrukoff LF, Paty DW (1989) Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 25: 43–49PubMedCrossRefGoogle Scholar
  36. Wolinsky JS, Narayana PA, Fenstermacher MJ, et al (1990) Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 40: 1764–1769PubMedGoogle Scholar
  37. Zhu G, Allen PS, Koopmans R, Li DK, Paty DW (1992) A marked elevation of inositol in MS lesions. SMRM. Book of Abstracts 1: 1948Google Scholar

Copyright information

© Springer-Verlag/Wien 1997

Authors and Affiliations

  • D. W. Paty
    • 1
  1. 1.Division of NeurologyThe University of British ColumbiaVancouverCanada

Personalised recommendations